Media
Femasys in the
Femasys in the
conversation.
Podcasts, press coverage, educational videos, webinars, blog posts, and press resources — everything you need to stay current on Femasys and our women’s health innovations.
Featured
News
August 2026
Femasys Secures $30 Million Private Placement, with Potential Proceeds of Up to $90 Million
Dec 18, 2025
Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device
GlobeNewswire
Read ↗
Nov 14, 2025
Femasys Announces Third Quarter Financial Results for 2025
GlobeNewswire
Read ↗
Nov 10, 2025
Femasys Advances Global Growth with Second Partner Order for FemBloc® in Europe
GlobeNewswire
Read ↗
Nov 5, 2025
How Femasys Is Using Innovation to Rethink Permanent Birth Control
MedTech Spectrum
Read ↗
Nov 3, 2025
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million
GlobeNewswire
Read ↗
Oct 29, 2025
Metro Atlanta woman invents a nonsurgical form of permanent birth control
Atlanta Journal-Constitution
Read ↗
Stay Current
Women’s health news, delivered.
Get the latest Femasys updates — from progress on FemaSeed® fertility commercialization and the FemBloc® U.S. clinical trial to educational events and press releases — delivered directly to your inbox.
You can unsubscribe from these communications at any time.
For more information on our privacy practices, and how we are committed to protecting and respecting your privacy, please review our Privacy Policy.